The Center for Hematology-Oncology
Boca Raton, Florida, United States
Medical clinic in Boca Raton, Florida
701 NW 13th St STE 2, Boca Raton, FL 33486
About The Center for Hematology-Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Center for Hematology-Oncology
During the past decade, The Center for Hematology-Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection
1998-06-01
Completed
96
A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers
1999-01-01
Completed
156
A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
2001-08-01
Completed
270
A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children
1998-04-01
Completed
45
A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants
1999-10-01
Completed
60
A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children
2005-11-01
Completed
127
Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children
1998-10-01
Completed
198
Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
2004-03-01
Completed
60
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Center for Hematology-Oncology" #1 sponsor was "Telik" with 4 trials, followed by "Abbott" with 2 trials
sponsored, "Agennix" with 2 trials sponsored, "Favrille" with 2 trials sponsored and "Sanofi"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Hematology-Oncology"
#1 collaborator was "CIRION Central Laboratory" with 1 trials as a collaborator, "Dorevitch" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "ORION Clinical Services" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at The Center for Hematology-Oncology
According to Clinical.Site data, the most researched conditions in "The Center for Hematology-Oncology" are
"Colorectal Cancer" (3 trials), "Prostate Cancer" (3 trials), "Lymphoma" (2 trials), "Ovarian Neoplasms" (2 trials) and "Adenocarcinoma of the Lung" (1 trials). Many other conditions were trialed in "The Center for Hematology-Oncology" in a lesser frequency.
Clinical Trials Intervention Types at The Center for Hematology-Oncology
Most popular intervention types in "The Center for Hematology-Oncology" are "Drug" (18 trials), "Biological" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "oxaliplatin" (3 trials), "Carboplatin" (2 trials), "FOLFOX regimen" (2 trials), "Prednisone" (2 trials) and "autologous immunoglobulin idiotype-KLH conjugate vaccine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at The Center for Hematology-Oncology
The vast majority of trials in "The Center for Hematology-Oncology" are
14 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at The Center for Hematology-Oncology
Currently, there are NaN active trials in "The Center for Hematology-Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in The Center for Hematology-Oncology,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in The Center for Hematology-Oncology, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".